(Q34540452)

2 August 2017

title

Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution (English)

1 reference

2 August 2017

1

Johannes Kornhuber

1 reference

2 August 2017

Jens Wiltfang

2

0 references

Stefan Bleich

series ordinal

4

object named as

Stefan Bleich

1 reference

2 August 2017

3

Peter Riederer

1 reference

2 August 2017

publication date

1 August 2006

1 reference

European Archives of Psychiatry and Clinical Neuroscience

2 August 2017

published in

1 reference

2 August 2017

volume

256

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

274-280

1 reference

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0661-7

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0661-7

Human brain fluoxetine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0661-7

Persistence of haloperidol in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0661-7

Oxidative Stress During Treatment With First- and Second-Generation Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0661-7

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

21 January 2018

1 reference

12 December 2020

Neuroleptic treatment and caudate plasticity

1 reference

12 December 2020

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

1 reference

12 December 2020

Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain

1 reference

12 December 2020

Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs

1 reference

12 December 2020

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

12 December 2020

Prolonged pharmacologic activity of neuroleptic drugs

1 reference

12 December 2020

The influence of some antidepressant drugs on the nuclear volume of rat cingular cortex cells in culture

1 reference

12 December 2020

Regional distribution of cytochrome P450 2D1 in the rat central nervous system.

1 reference

12 December 2020

Neuroleptic malignant syndrome: review and analysis of 115 cases

1 reference

12 December 2020

Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.

1 reference

12 December 2020

Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.

1 reference

12 December 2020

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

1 reference

12 December 2020

Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain.

1 reference

12 December 2020

The effects of various antidepressant drugs on the fine-structure of neurons of the cingulate cortex in culture

1 reference

12 December 2020

Reduced haloperidol in the post-mortem brains of haloperidol-treated patients

1 reference

12 December 2020

Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABA(A) receptors

1 reference

12 December 2020

Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study

1 reference

12 December 2020

Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes

1 reference

12 December 2020

Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.

1 reference

12 December 2020

Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup

1 reference

12 December 2020

Drug distribution between blood and brain as a determinant of antipsychotic drug effects

1 reference

12 December 2020

Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs

1 reference

12 December 2020

Oxidative stress during treatment with first- and second-generation antipsychotics

1 reference

12 December 2020

Xenobiotic metabolism in brain

1 reference

12 December 2020

Antidepressants and drug-metabolizing enzymes--expert group report

1 reference

12 December 2020

Distribution of clozapine and desmethylclozapine between blood and brain in rats

1 reference

12 December 2020

Effect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat

1 reference

12 December 2020

Blood to brain distribution of neuroleptics

1 reference

12 December 2020

Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study.

1 reference

12 December 2020

Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons

1 reference

12 December 2020

Region specific distribution of levomepromazine in the human brain

1 reference

12 December 2020

Tissue concentrations of clozapine and its metabolites in the rat

1 reference

12 December 2020

Fluoxetine inhibits K(+) transport pathways (K(+) efflux, Na(+)-K(+)-2Cl(-) cotransport, and Na(+) pump) underlying volume regulation in corneal endothelial cells

1 reference

12 December 2020

How to run a brain bank. A report from the Austro-German brain bank.

1 reference

12 December 2020

Striatal enlargement in rats chronically treated with neuroleptic.

1 reference

12 December 2020

Studies on the biologic disposition of methotrimeprazine.

1 reference

12 December 2020

Neuroleptic malignant syndrome

1 reference

12 December 2020

Pharmacokinetics of methotrimeprazine after single and multiple doses

1 reference

12 December 2020

Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs?

1 reference

12 December 2020

Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms

1 reference

12 December 2020

Plasma concentrations of antipsychotic drugs in psychiatric inpatients

1 reference

12 December 2020

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

1 reference

12 December 2020

Membrane mechanisms in volume and pH regulation in vertebrate cells

1 reference

12 December 2020

Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain

1 reference

12 December 2020

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

1 reference

12 December 2020

10.1007/S00406-006-0661-7

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1034360774

0 references

Fatcat ID

release_o4pab2frorf37ezj5shj3f2hf4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o4pab2frorf37ezj5shj3f2hf4

24 November 2022

mapped directly with Wikidata item

1 reference